ACT Brief: RBQM Analysis Frequency, Building Trust in Oncology Data, and Rare Pediatric PRV Monetization

0:00-1:50

In today's ACT Brief, we examine proportionate analysis frequency in RBQM, how to build trust into real-world evidence foundations for cancer trials, and how rare disease developers monetize regulatory success.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8962192

Published

October 9, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#rbqmanalysisfrequency #buildingtrust #rarepediatricprv #lifesciences

The Nile